MTOR and seminoma: Association was also identified for RAS/RAF with seminoma and extragonadal disease (p = 2.9 × 10−8 and p = 4.7 × 10−6, respectively) and PI3K/MTOR pathway with seminoma (p = 0.02, Fig. 3b).